Author:
Bisht Savita,Nolting Jens,Schütte Ute,Haarmann Jens,Jain Prashi,Shah Dhruv,Brossart Peter,Flaherty Patrick,Feldmann Georg
Funder
European Community's Seventh Framework Program
German Cancer Foundation (Deutsche Krebshilfe)
University Hospital of Bonn, BONFOR
Reference58 articles.
1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014
2. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;N Engl J Med,2012
3. Safety, activity, and immune correlates of anti–PD-1 antibody in cancer;Topalian;N Engl J Med,2012
4. Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas;Lito;Cancer Cell,2012
5. The intersection of immune-directed and molecularly targeted therapy in advanced melanoma: where we have been, are, and will be;Sullivan;Clin Cancer Res,2013
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献